Clinical trial · Interventional
Hepatoblastoma Biology Study and Tissue Bank
NCT00228683CI-TRIAL-00012756withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): national study, local site not responsible for any analysis/results/etc
Summary
Brief summary (as posted)
This is a study to collect and bank tissue specimens and blood from patients with Hepatoblastoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatoblastoma | Hepatoblastoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biology Study and Tissue Banking | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To collect and bank Hepatoblastoma specimens.
- timeFrame
- specimens will be banked indefinitely
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Months
- Maximum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with hepatoblastoma. Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.